VCM
ASND icon

Voleon Capital Management’s Ascendis Pharma A/S ASND Stock Holding History

Voleon Capital Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.5M Sell
67,839
-1,550
-2% -$347K 0.33% 61
2025
Q4 		$14.8M Buy
69,389
+37,463
+117% +$7.74M 0.32% 67
2025
Q3 		$6.35M Buy
+31,926
New +$5.95M 0.16% 137

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Voleon Capital Management's ASND Position: Q1 2026 in Review

Voleon Capital Management reduced its Ascendis Pharma A/S (ASND) stake by 2.2% in Q1 2026, selling an estimated $347K and leaving 67,839 shares worth $15.5M. The position accounts for 0.33% of the portfolio, ranked #61.

Voleon Capital Management first reported a position in ASND in Q3 2025 and has held it in 3 quarters since. 273 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

  • Voleon Capital Management held 67,839 shares of Ascendis Pharma A/S worth $15.5M as of Q1 2026.
  • Voleon Capital Management sold 1,550 Ascendis Pharma A/S shares in Q1 2026, an estimated $347K.
  • Ascendis Pharma A/S made up 0.33% of Voleon Capital Management's portfolio in Q1 2026, its #61 holding.
  • Voleon Capital Management first reported a position in Ascendis Pharma A/S in Q3 2025 and has held it in 3 quarters since.
  • 273 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.